Benitec Biopharma Limited EV/EBIT

EV/EBIT of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBIT growth rates and interactive chart. EV/EBIT is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes (EBIT), but after Depreciation and Amortization.. The EV/EBIT ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBIT compared to a stock’s historical average or industry can indicate undervaluation. EV/EBIT takes into account the reinvestment needs of a business (depreciation, amortization).

Highlights and Quick Summary

Current EV/EBIT of Benitec Biopharma Limited is 0.0 (as of June 30, 2022)
  • EV/EBIT for the quarter ending December 31, 2022 was 0.27 (a Infinity% increase compared to previous quarter)
  • Year-over-year quarterly EV/EBIT increased by Infinity%
  • Annual EV/EBIT for 2022 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBIT for 2022 was 0.0 (a -100.0% decrease from previous year)
  • Annual EV/EBIT for 2021 was 0.09 (a Infinity% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBIT of Benitec Biopharma Limited

Most recent EV/EBITof BNTC including historical data for past 10 years.

Interactive Chart of EV/EBIT of Benitec Biopharma Limited

Benitec Biopharma Limited EV/EBIT for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 0.27 0.0 0.0 0.0
2021 – 0.0 0.09 0.0 0.09
2020 0.07 0.02 1.12 2.3 1.12
2019 – – 0.0 0.0 0.0
2018 – – – – 0.0
2017 – – – 0.0 0.0
2016 – – – 0.0 0.0
2015 – – – – 0.0
2014 – – – – 0.0
2013 – – – – 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology
© stockrow.com